Pluxee Shares Rise 2.5% to €12.31 Following Jefferies' Target Upgrade
Pluxee shares climb 2.5% to €12.31 mid-session, within an SBF 120 up by 0.87%. The employee benefits specialist benefits from a target price upgrade by Jefferies this Tuesday. Meanwhile, its direct competitor Edenred sees a 4.37% increase.
Jefferies Raises Target to €11.90 and Maintains Hold Recommendation
Jefferies has issued a new review on Pluxee, raising its target price from €11.50 to €11.90 while maintaining a hold recommendation. The new target remains below the current price of €12.31, indicating an implicit downside potential of about 3.3% from the midday level.
Based on the consensus of twelve analysts recorded in mid-May, the stock is trading at approximately 8.3 times the expected earnings for the current fiscal year, compared to an Industrials sector average of about 17.8 times. The expected year-over-year earnings per share growth is estimated at 2.5%.
However, the stock is still down 39% over the year, after a 2025 marked by significant volatility. Today's rebound continues the recovery that began three months ago, with a performance of 10.6% over that period.
Stock Moves Above Its 20-Day Moving Average, Targeting €12.52 Resistance
The price at €12.31 moves above its 20-day moving average (€12.15) and remains 8.94% above its 50-day moving average (€11.30). However, it is still 9.15% below its 200-day moving average at €13.55, indicating that the medium-term trend has not yet been reestablished. The €12.52 resistance is now within reach, less than 2% from the current price.
The RSI at 55 indicates a slightly bullish momentum without excessive tension. In the Bollinger Bands, the price is in the upper part (74% of the amplitude), approaching the upper boundary at €12.49.
Today's rebound places Pluxee among the notable gains in the SBF 120, though not reaching the top ranks occupied by Worldline and Atos. The next financial milestone is the third quarter revenue report, scheduled for July 3, 2026.
